Skip to main content
Retour
Watch Compare

Picard Medical, Inc.

Qualité des données : 100%
PMI
NYSE Manufacturing Measuring & Analyzing Instruments
1,01 €
▼ 0,01 € (-0,98%)
Cap. Boursière: 75,93 M
Prix
1,01 €
Cap. Boursière
75,93 M
Fourchette du Jour
1,00 € — 1,05 €
Fourchette 52 Semaines
0,92 € — 13,68 €
Volume
35 218
Ouverture 1,03 €
Moyenne 50J / 200J
1,34 €
24,34% below
Moyenne 50J / 200J
3,65 €
72,33% below

Quick Summary

Points Clés

Negative free cash flow of -15,67 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-546,60%
Op. Margin-268,36%

Sécurité

Debt / Equity
N/A
Current Ratio2,16
Interest CoverageN/A

Valorisation

PE (TTM)
-2,81
En dessous de la moyenne du secteur (-1,98)
P/B Ratio9,53
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -2,8 -2,0
P/B 9,5 5,1
ROE % — -51,0
Net Margin % -546,6 -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4,94 M Net Income (TTM) -27,00 M
ROE N/A ROA -214,10%
Gross Margin -4,13% Operating Margin -268,36%
Net Margin -546,60% Free Cash Flow (TTM) -15,67 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,16
Interest Coverage N/A Asset Turnover 0,39
Working Capital 6,22 M Tangible Book Value 6,82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,81 Forward P/E N/A
P/B Ratio 9,53 P/S Ratio 15,37
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -20,64%
Market Cap 75,93 M Enterprise Value 73,12 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,07
FCF / Share -0,21 OCF / Share -0,21
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 58,04%
SBC-Adj. FCF -16,43 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue 4,94 M
Net Income -27,00 M
EPS (Diluted) —
Gross Profit -204 000,0
Operating Income -13,26 M
EBITDA —
R&D Expenses 3,05 M
SG&A Expenses 10,00 M
D&A 163 000,0
Interest Expense —
Income Tax 35 000,0

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 22,55 M
Total Liabilities 18,76 M
Shareholders' Equity 3,79 M
Total Debt —
Cash & Equivalents 7,45 M
Current Assets 20,73 M
Current Liabilities 18,70 M